Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
449.00    4.00 (0.90%)
Bid:
448.50
Ask:
449.50
Spread: 1.00 (0.223%)
Market Cap: £664.09m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Pre-CloseTrading Statement

27 Sep 2007 07:03

Creston PLC27 September 2007 27 September 2007 Creston plc Pre-close trading statement Creston plc, the Insight and Communications Group, issues the following tradingupdate for the six month period to 30 September 2007 in advance of announcingits interim results on 30 November. The Board has been pleased with the number and size of the new business wins,which have demonstrated the quality and industry standing of the Groupcompanies. New client wins across the Group include Alton Towers, Capital One,Freeview, GlaxoSmithKline, Intercontinental Hotels Group, Pricerunner.co.uk,Royal Mail, Smart cars and Telstra. In addition to these wins, there have been major new project and brand wins fromexisting clients such as AstraZeneca, Capital Radio, Infinti from Nissan, directmarketing consultancy for Numico in Austria and Thailand, Opel, Roche, SainsburyBank from Sainsbury's, Slim Fast from Unilever, Vauxhall, and Sunbites fromWalkers Crisps. Cross-selling between Creston's operating companies has also been verysuccessful in the period with new projects being won from several clientsincluding AstraZeneca, Morrisons, Servier, Stihl and Toshiba. The Board is confident that the wins will maintain a similar like for likerevenue growth that was reported at 12% for the first quarter. Digital and on-line projects continue to grow as a proportion of revenues and wehave increased our investment in specialist staff to match this development.This necessary investment will have a very minor impact on first half operatingmargin. The balance sheet is strong and we have substantial unutilised bank facilities.The Board retains the flexibility to settle earn out liabilities predominantlyin cash and loan notes rather than the issue of shares, as was demonstrated inthe settlement of the two earn outs in June of this year, which were 100% inloan notes. The Group has continued to perform well in the first half of the yeardemonstrating its ability to deliver growth as a diversified Insight andCommunications Group. The new business pipeline continues to be strong withmajor pitches planned across all companies and we are confident that oursuccessful pitch to win ratio will ensure a positive impact for the rest of thefinancial year. For further information, please contact: Creston plc Tel: 020 7930 9757Don Elgie, Chief ExecutiveBarrie Brien, COO & CFOwww.creston.com Hogarth Partnership Limited Tel: 020 7357 9477Chris Matthews / Sarah Macleod / Sarah Richardson This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.